(Q34204611)

31 July 2017

1 reference

title

Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. (English)

1 reference

31 July 2017

Abuja PM

1

1 reference

31 July 2017

Albertini R

series ordinal

2

1 reference

31 July 2017

publication date

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

306

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

1-17

1 reference

Chemistry of lipid peroxidation

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

How to characterize a biological antioxidant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Markers of inflammation as predictors in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Pathogenesis of atherosclerosis: a possible relation to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Low density lipoprotein oxidation and its pathobiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Low density lipoprotein undergoes oxidative modification in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

In search of biological markers of high-risk carotid artery atherosclerotic plaque: enhanced LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Analogues of nucleic acid derivatives and the growth and development of Rana pipiens. I. The cyclic inhibition of the development of rana pipiens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Imbalance of oxidants and antioxidants in haemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

A Modified Form of Low-Density Lipoprotein with Increased Electronegative Charge is Present in Rheumatoid Arthritis Synovial Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The C1q binding activity of IgG is modified in vitro by reactive oxygen species: implications for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Myocardial reperfusion injury: mechanisms and management--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Direct measurement of free radical generation following reperfusion of ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation. Is the hydroxyl radical really the most damaging radical species?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

PEG-SOD and myocardial antioxidant status during ischaemia and reperfusion: dose-response studies in the isolated blood perfused rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Toxic properties of arachidonic acid on normal, ischemic and reperfused hearts. Indirect evidence for free radical involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Is the autoxidation of catecholamines involved in ischemia-reperfusion injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Continuous monitoring of in vitro oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Simulation of the induction of oxidation of low-density lipoprotein by high copper concentrations: evidence for a nonconstant rate of initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Visible-range low-level chemiluminescence in biological systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Monitoring of low density lipoprotein oxidation by low-level chemiluminescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Is there an unidentified defence mechanism against infection in human plasma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Total antioxidant status in plasma and body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Phycoerythrin fluorescence-based assay for reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Effects of Acute Prolonged Exercise on Serum and LDL Oxidation and Antioxidant Defences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Does a relationship exist between the urate pool in the body and lipid peroxidation during exercise?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Oxygen-radical absorbance capacity assay for antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Measurement of oxygen radical absorbance capacity in biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

On the antioxidant activity of melatonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Evaluation of plasma low molecular weight antioxidant capacity by cyclic voltammetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Simultaneous detection of reduced and oxidized glutathione in tissues and mitochondria by capillary electrophoresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Blood glutathione homeostasis as a determinant of resting and exercise-induced oxidative stress in young men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Analysis of ascorbic acid and dehydroascorbic acid in biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Bicarbonate promotes a cleavage of lactone ring of dehydroascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Cysteine and ascorbate loss in the diabetic rat lens prior to hydration changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Analysis of lipoprotein diene formation in human serum exposed to copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

IPF2alpha-I: an index of lipid peroxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Measurement of lipid hydroperoxides in human plasma and lipoproteins by kinetic analysis of photon emission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Enzymatic determination of membrane lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Presence of lipid hydroperoxide in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Iodometric measurement of lipid hydroperoxides in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900393-X

10.1016/S0009-8981(01)00393-X

7 January 2021

Identifiers

DOI

1 reference

release_vi4khscfz5adxjdg52srmh7vsu

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vi4khscfz5adxjdg52srmh7vsu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference